Quest Diagnostics Incorporated Company Profile (NYSE:DGX)

About Quest Diagnostics Incorporated (NYSE:DGX)

Quest Diagnostics Incorporated logoQuest Diagnostics Incorporated is a provider of diagnostic information services. The Company operates through two businesses: Diagnostic Information Services and Diagnostic Solutions. The Diagnostic Information Services business develops and delivers diagnostic testing information and services, providing insights that empower and enable a range of customers, including patients, clinicians, hospitals, integrated delivery networks (IDNs), health plans, employers and accountable care organizations (ACOs). Its Diagnostic Solutions group includes its risk assessment services business, which offers solutions for insurers, and its healthcare information technology businesses, which offers solutions for healthcare providers. The Company's services are provided under the Quest Diagnostics brand, but it also provides services under other brands, including AmeriPath, Dermpath Diagnostics, Focus Diagnostics, Athena Diagnostics, ExamOne, Quanum and Care360.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Healthcare Facilities & Services
  • Sub-Industry: Health Care Services
  • Symbol: NYSE:DGX
  • CUSIP: 74834L10
  • Web: www.questdiagnostics.com
Capitalization:
  • Market Cap: $13.85 billion
  • Outstanding Shares: 136,405,000
Average Prices:
  • 50 Day Moving Avg: $106.58
  • 200 Day Moving Avg: $105.42
  • 52 Week Range: $79.12 - $112.97
P/E:
  • Trailing P/E Ratio: 20.47
  • Foreward P/E Ratio: 17.04
  • P/E Growth: 2.29
Sales & Book Value:
  • Annual Revenue: $7.59 billion
  • Price / Sales: 1.83
  • Book Value: $34.54 per share
  • Price / Book: 2.94
Dividend:
  • Annual Dividend: $1.80
  • Dividend Yield: 1.8%
Profitability:
  • EBIDTA: $1.44 billion
  • Net Margins: 9.28%
  • Return on Equity: 15.66%
  • Return on Assets: 7.24%
Debt:
  • Debt-to-Equity Ratio: 0.79%
  • Current Ratio: 1.64%
  • Quick Ratio: 1.55%
Misc:
  • Average Volume: 817,336 shs.
  • Beta: 0.69
  • Short Ratio: 5.9
 

Frequently Asked Questions for Quest Diagnostics Incorporated (NYSE:DGX)

What is Quest Diagnostics Incorporated's stock symbol?

Quest Diagnostics Incorporated trades on the New York Stock Exchange (NYSE) under the ticker symbol "DGX."

How often does Quest Diagnostics Incorporated pay dividends? What is the dividend yield for Quest Diagnostics Incorporated?

Quest Diagnostics Incorporated announced a quarterly dividend on Friday, August 18th. Shareholders of record on Tuesday, October 3rd will be given a dividend of $0.45 per share on Wednesday, October 18th. This represents a $1.80 dividend on an annualized basis and a yield of 1.77%. The ex-dividend date of this dividend is Monday, October 2nd. View Quest Diagnostics Incorporated's Dividend History.

How will Quest Diagnostics Incorporated's stock buyback program work?

Quest Diagnostics Incorporated declared that its Board of Directors has approved a stock buyback program on Sunday, April 9th 2017, which permits the company to repurchase $1,000,000,000.00 in shares, according to EventVestor. This repurchase authorization permits the company to repurchase up to 7.8% of its stock through open market purchases. Stock repurchase programs are often a sign that the company's management believes its shares are undervalued.

How were Quest Diagnostics Incorporated's earnings last quarter?

Quest Diagnostics Incorporated (NYSE:DGX) released its earnings results on Tuesday, July, 25th. The company reported $1.55 EPS for the quarter, beating the Zacks' consensus estimate of $1.42 by $0.13. The business earned $1.94 billion during the quarter, compared to the consensus estimate of $1.94 billion. Quest Diagnostics Incorporated had a net margin of 9.28% and a return on equity of 15.66%. The company's revenue for the quarter was up 1.9% compared to the same quarter last year. During the same quarter last year, the company earned $1.34 EPS. View Quest Diagnostics Incorporated's Earnings History.

When will Quest Diagnostics Incorporated make its next earnings announcement?

Quest Diagnostics Incorporated is scheduled to release their next quarterly earnings announcement on Thursday, October, 19th 2017. View Earnings Estimates for Quest Diagnostics Incorporated.

What guidance has Quest Diagnostics Incorporated issued on next quarter's earnings?

Quest Diagnostics Incorporated updated its FY17 earnings guidance on Tuesday, July, 25th. The company provided earnings per share (EPS) guidance of $5.62-5.72 for the period, compared to the Thomson Reuters consensus estimate of $5.57. The company issued revenue guidance of $7.69-7.74 billion, compared to the consensus revenue estimate of $7.69 billion.

Where is Quest Diagnostics Incorporated's stock going? Where will Quest Diagnostics Incorporated's stock price be in 2017?

14 equities research analysts have issued twelve-month target prices for Quest Diagnostics Incorporated's shares. Their predictions range from $92.00 to $122.00. On average, they expect Quest Diagnostics Incorporated's stock price to reach $109.54 in the next year. View Analyst Ratings for Quest Diagnostics Incorporated.

Who are some of Quest Diagnostics Incorporated's key competitors?

Who are Quest Diagnostics Incorporated's key executives?

Quest Diagnostics Incorporated's management team includes the folowing people:

  • Stephen H. Rusckowski, Chairman of the Board, President, Chief Executive Officer
  • Mark J. Guinan, Chief Financial Officer, Executive Vice President
  • James E. Davis, Executive Vice President, General Diagnostics
  • Michael E. Prevoznik, Senior Vice President, General Counsel
  • Jon Roger Cohen M.D., Senior Vice President, Group Executive - Diagnostic Solutions
  • Everett V. Cunningham, Senior Vice President - Commercial
  • Catherine T. Doherty, Senior Vice President, Group Executive - Clinical Franchise Solutions and Marketing
  • Carrie Eglinton Manner, Senior Vice President - Advanced Diagnostics
  • Daniel C. Stanzione Ph.D., Lead Independent Director
  • Jenne K. Britell Ph.D., Independent Director

Who owns Quest Diagnostics Incorporated stock?

Quest Diagnostics Incorporated's stock is owned by a variety of of institutional and retail investors. Top institutional investors include BlackRock Inc. (11.00%), Vanguard Group Inc. (10.29%), Macquarie Group Ltd. (5.34%), State Street Corp (5.00%), Investec Asset Management LTD (1.60%) and AJO LP (1.56%). Company insiders that own Quest Diagnostics Incorporated stock include Catherine T Doherty, Daniel Stanzione, Everett Cunningham, Jeffrey M Leiden, Jenne K Britell, John B Ziegler, Michael E Prevoznik and Stephen H Rusckowski. View Institutional Ownership Trends for Quest Diagnostics Incorporated.

Who sold Quest Diagnostics Incorporated stock? Who is selling Quest Diagnostics Incorporated stock?

Quest Diagnostics Incorporated's stock was sold by a variety of institutional investors in the last quarter, including Schroder Investment Management Group, LSV Asset Management, Macquarie Group Ltd., Bessemer Group Inc., American Century Companies Inc., BlackRock Inc., Bank of New York Mellon Corp and Victory Capital Management Inc.. Company insiders that have sold Quest Diagnostics Incorporated stock in the last year include Catherine T Doherty, Daniel Stanzione, Jeffrey M Leiden, Jenne K Britell, Michael E Prevoznik and Stephen H Rusckowski. View Insider Buying and Selling for Quest Diagnostics Incorporated.

Who bought Quest Diagnostics Incorporated stock? Who is buying Quest Diagnostics Incorporated stock?

Quest Diagnostics Incorporated's stock was acquired by a variety of institutional investors in the last quarter, including Janus Henderson Group PLC, AJO LP, Robeco Institutional Asset Management B.V., Vanguard Group Inc., Alliancebernstein L.P., FMR LLC, JPMorgan Chase & Co. and Ardevora Asset Management LLP. View Insider Buying and Selling for Quest Diagnostics Incorporated.

How do I buy Quest Diagnostics Incorporated stock?

Shares of Quest Diagnostics Incorporated can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Quest Diagnostics Incorporated's stock price today?

One share of Quest Diagnostics Incorporated stock can currently be purchased for approximately $101.55.


MarketBeat Community Rating for Quest Diagnostics Incorporated (NYSE DGX)
Community Ranking:  1.7 out of 5 (star)
Outperform Votes:  257 (Vote Outperform)
Underperform Votes:  517 (Vote Underperform)
Total Votes:  774
MarketBeat's community ratings are surveys of what our community members think about Quest Diagnostics Incorporated and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Quest Diagnostics Incorporated (NYSE:DGX) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 1 Sell Rating, 6 Hold Ratings, 6 Buy Ratings, 1 Strong Buy Rating
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: $109.54 (7.86% upside)

Analysts' Ratings History for Quest Diagnostics Incorporated (NYSE:DGX)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
9/13/2017Canaccord GenuityReiterated RatingBuy$118.00MediumView Rating Details
8/10/2017Morgan StanleyBoost Price TargetUnderweight$87.00 -> $92.00LowView Rating Details
7/25/2017Bank of America CorporationUpgradeNeutral -> Buy$111.00 -> $118.00MediumView Rating Details
7/25/2017Piper Jaffray CompaniesBoost Price TargetNeutral$107.00HighView Rating Details
7/19/2017Barclays PLCReiterated RatingHold$110.00LowView Rating Details
7/13/2017Credit Suisse GroupReiterated RatingNeutral$83.00 -> $110.00LowView Rating Details
6/28/2017Evercore ISIReiterated RatingIn-Line$104.50LowView Rating Details
6/5/2017MizuhoBoost Price TargetBuy -> Buy$115.00 -> $122.00LowView Rating Details
5/12/2017ArgusInitiated CoverageHold -> Hold$102.00LowView Rating Details
4/23/2017Deutsche Bank AGReiterated RatingBuy$108.00 -> $115.00LowView Rating Details
4/21/2017Raymond James Financial, Inc.UpgradeMarket Perform -> Outperform$116.00LowView Rating Details
4/12/2017FBR & CoBoost Price TargetOutperform$103.00 -> $110.00LowView Rating Details
3/16/2017Jefferies Group LLCReiterated RatingHold$96.00MediumView Rating Details
3/14/2017Goldman Sachs Group, Inc. (The)UpgradeBuy -> Conviction-Buy$113.00LowView Rating Details
9/9/2016Citigroup Inc.Initiated CoverageNeutral$86.00N/AView Rating Details
6/24/2016Jyske BankDowngradeNeutral -> SellN/AView Rating Details
5/22/2016KeyCorpReiterated RatingHoldN/AView Rating Details
5/16/2016Robert W. BairdReiterated RatingHoldN/AView Rating Details
4/22/2016Royal Bank Of CanadaBoost Price TargetSector Perform$70.00 -> $76.00N/AView Rating Details
1/29/2016William BlairReiterated RatingHoldN/AView Rating Details
10/16/2015Wells Fargo & CompanyUpgradeUnderperform -> Market PerformN/AView Rating Details
(Data available from 9/22/2015 forward)

Earnings

Earnings History for Quest Diagnostics Incorporated (NYSE:DGX)
Earnings by Quarter for Quest Diagnostics Incorporated (NYSE:DGX)
Earnings History by Quarter for Quest Diagnostics Incorporated (NYSE DGX)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/19/2017$1.43N/AView Earnings Details
7/25/2017Q2 2017$1.42$1.55$1.94 billion$1.94 billionViewN/AView Earnings Details
4/20/2017Q1 2017$1.18$1.33$1.87 billion$1.90 billionViewN/AView Earnings Details
1/26/2017Q416$1.27$1.31$1.86 billion$1.86 billionViewListenView Earnings Details
10/20/2016Q316$1.35$1.37$1.53 billion$1.89 billionViewListenView Earnings Details
7/21/2016Q216$1.32$1.34$1.91 billion$1.91 billionViewListenView Earnings Details
4/21/2016Q116$1.12$1.12$1.82 billion$1.86 billionViewListenView Earnings Details
1/28/2016Q415$1.19$1.19$1.85 billion$1.85 billionViewListenView Earnings Details
10/22/2015Q315$1.26$1.28$1.89 billion$1.88 billionViewListenView Earnings Details
7/23/2015Q215$1.23$1.25$1.93 billion$1.93 billionViewListenView Earnings Details
4/23/2015Q115$1.04$1.05$1.85 billion$1.84 billionViewListenView Earnings Details
1/29/2015Q414$1.05$1.08$1.85 billion$1.90 billionViewListenView Earnings Details
10/23/2014Q314$1.08$1.10$1.87 billion$1.90 billionViewListenView Earnings Details
7/24/2014Q214$1.06$1.08$1.88 billion$1.90 billionViewN/AView Earnings Details
4/24/2014Q114$0.89$0.84$1.75 billion$1.75 billionViewListenView Earnings Details
1/30/2014Q413$0.93$0.97$1.74 billion$1.76 billionViewListenView Earnings Details
10/17/2013Q313$1.20$1.02$1.84 billion$1.79 billionViewListenView Earnings Details
7/18/2013Q2 2013$1.10$1.06$1.84 billion$1.82 billionViewListenView Earnings Details
4/17/2013Q1 2013$1.03$0.89$1.86 billion$1.80 billionViewListenView Earnings Details
1/23/2013Q4 2012$1.02$1.01$1.83 billion$1.77 billionViewListenView Earnings Details
10/17/2012$1.18$1.18ViewN/AView Earnings Details
7/19/2012$1.17$1.17ViewN/AView Earnings Details
4/18/2012$1.01$1.07ViewN/AView Earnings Details
1/24/2012$1.06$1.23ViewN/AView Earnings Details
10/25/2011$1.11$1.18ViewN/AView Earnings Details
7/20/2011$1.12$1.12ViewN/AView Earnings Details
4/20/2011$1.01$1.00ViewN/AView Earnings Details
1/25/2011$0.91$0.98ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Quest Diagnostics Incorporated (NYSE:DGX)
2017 EPS Consensus Estimate: $5.39
2018 EPS Consensus Estimate: $5.92
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20174$1.16$1.18$1.17
Q2 20175$1.39$1.43$1.42
Q3 20175$1.34$1.45$1.42
Q4 20175$1.36$1.45$1.39
Q1 20183$1.30$1.38$1.35
Q2 20183$1.55$1.56$1.55
Q3 20183$1.53$1.56$1.54
Q4 20183$1.46$1.51$1.48
Q1 20191$1.52$1.52$1.52
Q2 20191$1.67$1.67$1.67
(Data provided by Zacks Investment Research)

Dividends

Current Dividend Information for Quest Diagnostics Incorporated (NYSE:DGX)
Next Dividend:10/18/2017
Annual Dividend:$1.80
Dividend Yield:1.77%
Dividend Growth:9.60% (3 Year Average)
Payout Ratio:36.29% (Trailing 12 Months of Earnings)
31.63% (Based on This Year's Estimates)
30.20% (Based on Next Year's Estimates)
Track Record:5 Years of Consecutive Dividend Growth
Dividend Payments by Quarter for Quest Diagnostics Incorporated (NYSE:DGX)

Dividend History by Quarter for Quest Diagnostics Incorporated (NYSE DGX)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
8/18/2017quarterly$0.451.72%10/2/201710/3/201710/18/2017
5/16/2017quarterly$0.451.71%7/6/20177/10/20177/24/2017
2/21/2017quarterly$0.451.88%4/3/20174/5/20174/19/2017
11/11/2016quarterly$0.451/6/20171/10/20171/25/2017
8/17/2016quarterly$0.401.88%9/30/201610/4/201610/19/2016
5/18/2016quarterly$0.402.1%7/1/20167/6/20167/20/2016
1/28/2016quarterly$0.402.31%4/4/20164/6/20164/20/2016
12/4/2015quarterly$0.382.22%1/8/20161/12/20161/27/2016
8/18/2015quarterly$0.382.07%10/2/201510/6/201510/21/2015
5/15/2015quarterly$0.382.09%7/6/20157/8/20157/22/2015
1/29/2015quarterly$0.382.13%4/6/20154/8/20154/22/2015
12/4/2014quarterly$0.332.03%1/9/20151/13/20151/28/2015
8/15/2014quarterly$0.332.14%10/3/201410/7/201410/22/2014
5/21/2014quarterly$0.332.3%7/7/20147/9/20147/23/2014
1/30/2014quarterly$0.332.51%4/4/20144/8/20144/23/2014
12/6/2013quarterly$0.301.99%1/3/20141/7/20141/22/2014
8/20/2013quarterly$0.302.03%9/27/201310/1/201310/16/2013
5/21/2013quarterly$0.301.96%6/28/20137/2/20137/17/2013
2/26/2013quarterly$0.302.14%3/28/20134/2/20134/16/2013
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading and Institutional Ownership History for Quest Diagnostics Incorporated (NYSE:DGX)
Insider Ownership Percentage: 1.75%
Institutional Ownership Percentage: 87.10%
Insider Trades by Quarter for Quest Diagnostics Incorporated (NYSE:DGX)
Institutional Ownership by Quarter for Quest Diagnostics Incorporated (NYSE:DGX)
Insider Trades by Quarter for Quest Diagnostics Incorporated (NYSE:DGX)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/12/2017Stephen H RusckowskiChairmanSell59,235$108.16$6,406,857.60View SEC Filing  
9/11/2017Daniel StanzioneDirectorSell40,900$108.07$4,420,063.00View SEC Filing  
9/11/2017Stephen H RusckowskiCEOSell53,933$108.16$5,833,393.28View SEC Filing  
9/5/2017Daniel StanzioneDirectorSell3,803$108.01$410,762.03View SEC Filing  
9/5/2017Stephen H RusckowskiChairmanSell2,525$108.03$272,775.75View SEC Filing  
8/4/2017Jeffrey M LeidenDirectorSell296$106.66$31,571.36View SEC Filing  
7/27/2017Jeffrey M LeidenDirectorSell1,304$108.73$141,783.92View SEC Filing  
6/19/2017Catherine T DohertySVPSell59,762$107.55$6,427,403.10View SEC Filing  
4/24/2017Jenne K BritellDirectorSell6,111$104.03$635,727.33View SEC Filing  
4/20/2017Michael E PrevoznikSVPSell29,513$100.00$2,951,300.00View SEC Filing  
3/16/2017Michael E PrevoznikSVPSell13,987$100.00$1,398,700.00View SEC Filing  
3/3/2017Catherine T DohertySVPSell7,162$98.28$703,881.36View SEC Filing  
2/27/2017Michael E PrevoznikSVPSell440$97.39$42,851.60View SEC Filing  
1/30/2017Catherine T DohertySVPSell80,000$90.58$7,246,400.00View SEC Filing  
8/19/2016Jenne K BritellDirectorSell4,000$84.76$339,040.00View SEC Filing  
8/10/2016Jenne K BritellDirectorSell4,000$85.20$340,800.00View SEC Filing  
8/3/2016Jeffrey M LeidenDirectorSell6,345$85.62$543,258.90View SEC Filing  
7/25/2016John B. ZieglerDirectorSell1,000$84.36$84,360.00View SEC Filing  
5/27/2016Catherine T DohertySVPSell47,334$77.27$3,657,498.18View SEC Filing  
5/12/2016Jenne K BritellDirectorSell8,000$75.68$605,440.00View SEC Filing  
5/9/2016Everett CunninghamSVPSell56,312$76.26$4,294,353.12View SEC Filing  
5/6/2016Everett CunninghamSVPSell50,447$76.00$3,833,972.00View SEC Filing  
4/25/2016Catherine T DohertySVPSell29,550$74.45$2,199,997.50View SEC Filing  
3/3/2015Michael E PrevoznikSVPSell3,261$71.16$232,052.76View SEC Filing  
2/11/2015Daniel StanzioneDirectorSell8,000$70.97$567,760.00View SEC Filing  
2/4/2015Gail R WilenskyDirectorSell8,000$72.34$578,720.00View SEC Filing  
2/3/2015John B ZieglerDirectorSell8,000$71.88$575,040.00View SEC Filing  
2/2/2015Thomas F BongiornoVPSell3,000$71.50$214,500.00View SEC Filing  
11/17/2014Jon R CohenSVPSell160,029$63.13$10,102,630.77View SEC Filing  
8/8/2014Catherine T DohertySVPSell25,000$60.12$1,503,000.00View SEC Filing  
8/4/2014Michael E PrevoznikSVPSell14,377$61.01$877,140.77View SEC Filing  
7/30/2014Jenne K BritellDirectorSell8,000$62.37$498,960.00View SEC Filing  
7/30/2014Michael E PrevoznikSVPSell16,384$62.51$1,024,163.84View SEC Filing  
7/29/2014John C Md BaldwinDirectorSell8,000$62.31$498,480.00View SEC Filing  
7/28/2014Thomas F BongiornoVPSell4,000$61.72$246,880.00View SEC Filing  
7/25/2014John B ZieglerDirectorSell8,000$61.90$495,200.00View SEC Filing  
5/22/2014John ZieglerDirectorSell2,973$57.65$171,393.45View SEC Filing  
5/7/2014Gary PfeifferDirectorSell10,000$55.95$559,500.00View SEC Filing  
5/5/2014Mark GuinanCFOBuy4,000$55.51$222,040.00View SEC Filing  
2/27/2014Jenne BritellDirectorSell10,000$52.74$527,400.00View SEC Filing  
2/19/2014Michael PrevoznikSVPSell2,860$52.26$149,463.60View SEC Filing  
2/18/2014Gail WilenskyDirectorSell30,000$52.93$1,587,900.00View SEC Filing  
2/6/2014Timothy MainDirectorBuy5,000$50.71$253,550.00View SEC Filing  
11/5/2013Thomas F BongiornoVPSell16,667$62.49$1,041,520.83View SEC Filing  
10/29/2013Thomas F BongiornoVPSell6,000$59.00$354,000.00View SEC Filing  
10/25/2013Gary M PfeifferDirectorSell2,000$58.10$116,200.00View SEC Filing  
9/17/2013Catherine DohertySVPSell43,334$62.00$2,686,708.00View SEC Filing  
8/14/2013Catherine DohertySVPSell33,000$59.85$1,975,050.00View SEC Filing  
8/12/2013John ZieglerDirectorSell1,953$59.45$116,105.85View SEC Filing  
8/8/2013Thomas BongiornoVPSell10,864$59.33$644,561.12View SEC Filing  
7/23/2013Jenne K BritellDirectorSell4,200$58.99$247,758.00View SEC Filing  
6/18/2013Michael E PrevoznikSVPSell126,667$62.64$7,934,420.88View SEC Filing  
5/22/2013John B ZieglerDirectorSell31,362$62.00$1,944,444.00View SEC Filing  
5/14/2013John C Md BaldwinDirectorSell1,214$59.41$72,123.74View SEC Filing  
4/11/2013John B ZieglerDirectorSell1,470$58.35$85,774.50View SEC Filing  
1/17/2013Gary M PfeifferDirectorSell10,000$60.00$600,000.00View SEC Filing  
10/3/2012Robert HagemannCFOSell46,667$64.00$2,986,688.00View SEC Filing  
8/7/2012Stephen H RusckowskiCEOBuy5,000$59.34$296,700.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Quest Diagnostics Incorporated (NYSE:DGX)
Latest Headlines for Quest Diagnostics Incorporated (NYSE:DGX)
Source:
DateHeadline
americanbankingnews.com logoHead to Head Comparison: Quest Diagnostics (DGX) and The Competition
www.americanbankingnews.com - September 20 at 8:08 AM
nasdaq.com logoInteresting DGX Put And Call Options For May 2018
www.nasdaq.com - September 20 at 3:58 AM
nasdaq.com logoDGX Crosses Below Key Moving Average Level
www.nasdaq.com - September 19 at 5:52 PM
nasdaq.com logoQuest Diagnostics is Oversold
www.nasdaq.com - September 18 at 5:49 PM
finance.yahoo.com logoMyriad Genetics Presents Favorable riskScore Test Data
finance.yahoo.com - September 18 at 5:48 PM
americanbankingnews.com logoBrokers Set Expectations for Quest Diagnostics Incorporated's Q1 2019 Earnings (DGX)
www.americanbankingnews.com - September 18 at 8:26 AM
finance.yahoo.com logoQuest Diagnostics Inc (DGX) Chairman, President and CEO Stephen H Rusckowski Sold $6. ...
finance.yahoo.com - September 14 at 6:42 PM
finance.yahoo.com logoQuest Diagnostics Sustainability Efforts Earn Place on DJSI World Index for Fourteenth Consecutive Year
finance.yahoo.com - September 14 at 6:42 PM
americanbankingnews.com logoQ3 2017 EPS Estimates for Quest Diagnostics Incorporated Decreased by William Blair (DGX)
www.americanbankingnews.com - September 14 at 6:58 AM
americanbankingnews.com logo$1.94 Billion in Sales Expected for Quest Diagnostics Incorporated (DGX) This Quarter
www.americanbankingnews.com - September 14 at 2:06 AM
americanbankingnews.com logoQuest Diagnostics' (DGX) Buy Rating Reiterated at Canaccord Genuity
www.americanbankingnews.com - September 13 at 8:32 PM
americanbankingnews.com logoStephen H. Rusckowski Sells 53,933 Shares of Quest Diagnostics Incorporated (DGX) Stock
www.americanbankingnews.com - September 13 at 7:38 PM
americanbankingnews.com logoStephen H. Rusckowski Sells 59,235 Shares of Quest Diagnostics Incorporated (DGX) Stock
www.americanbankingnews.com - September 13 at 7:16 PM
americanbankingnews.com logoQuest Diagnostics Incorporated (DGX) Director Daniel Stanzione Sells 40,900 Shares
www.americanbankingnews.com - September 13 at 7:16 PM
americanbankingnews.com logoQuest Diagnostics Incorporated (DGX) Expected to Announce Earnings of $1.43 Per Share
www.americanbankingnews.com - September 12 at 10:22 PM
finance.yahoo.com logoQuest Diagnostics, Inc. breached its 50 day moving average in a Bullish Manner : DGX-US : September 12, 2017
finance.yahoo.com - September 12 at 6:38 PM
americanbankingnews.com logoInsider Selling: Quest Diagnostics Incorporated (DGX) Chairman Sells 2,525 Shares of Stock
www.americanbankingnews.com - September 7 at 7:44 PM
americanbankingnews.com logoInsider Selling: Quest Diagnostics Incorporated (DGX) Director Sells 3,803 Shares of Stock
www.americanbankingnews.com - September 7 at 7:42 PM
finance.yahoo.com logoQuest to offer cholesterol testing without fasting requirement
finance.yahoo.com - September 7 at 5:59 PM
finance.yahoo.com logoQuest Diagnostics Moves to Convenient Nonfasting Cholesterol Testing with Improved Method for Assessing Heart Disease Risk and Aiding Treatment Decisions
finance.yahoo.com - September 7 at 5:59 PM
finance.yahoo.com logoMyriad Genetics Boosts myRisk Hereditary Cancer Test Suite
finance.yahoo.com - September 6 at 5:52 PM
finance.yahoo.com logoHalf of Americans Tested Misuse Their Prescription Medications
finance.yahoo.com - September 6 at 5:52 PM
finance.yahoo.com logoQuest Diagnostics To Speak At The Morgan Stanley Global Healthcare Conference
finance.yahoo.com - September 6 at 5:52 PM
finance.yahoo.com logoQuest Diagnostics, Inc. – Value Analysis (NYSE:DGX) : September 6, 2017
finance.yahoo.com - September 6 at 12:28 AM
americanbankingnews.com logoQuest Diagnostics Incorporated (DGX) Upgraded to Buy by ValuEngine
www.americanbankingnews.com - September 3 at 3:20 PM
americanbankingnews.com logoQuest Diagnostics Incorporated (DGX) Receives Average Recommendation of "Hold" from Analysts
www.americanbankingnews.com - September 2 at 2:38 PM
finance.yahoo.com logoQuest Diagnostics, Inc. breached its 50 day moving average in a Bullish Manner : DGX-US : September 1, 2017
finance.yahoo.com - September 1 at 6:12 PM
nasdaq.com logoWhy Is Quest Diagnostics (DGX) Down 3.9% Since the Last Earnings Report? - Nasdaq
www.nasdaq.com - August 30 at 6:56 PM
prnewswire.com logoMedical Research Stocks on Investors' Radar -- China Cord Blood, VWR Corp., Quest Diagnostics, and LabCorp
www.prnewswire.com - August 29 at 6:18 PM
finance.yahoo.com logoWhy Is Quest Diagnostics (DGX) Down 3.9% Since the Last Earnings Report?
finance.yahoo.com - August 28 at 5:39 PM
americanbankingnews.com logoQuest Diagnostics Incorporated (DGX) Expected to Post Quarterly Sales of $1.94 Billion
www.americanbankingnews.com - August 27 at 8:56 AM
americanbankingnews.com logo$1.43 Earnings Per Share Expected for Quest Diagnostics Incorporated (DGX) This Quarter
www.americanbankingnews.com - August 25 at 10:14 AM
nasdaq.com logoQuest Diagnostics Enters Oversold Territory
www.nasdaq.com - August 18 at 5:51 PM
finance.yahoo.com logoETFs with exposure to Quest Diagnostics, Inc. : August 18, 2017
finance.yahoo.com - August 18 at 5:51 PM
americanbankingnews.com logoQuest Diagnostics Incorporated (DGX) Announces $0.45 Quarterly Dividend
www.americanbankingnews.com - August 18 at 9:42 AM
finance.yahoo.com logoSee what the IHS Markit Score report has to say about Quest Diagnostics Inc.
finance.yahoo.com - August 12 at 5:16 PM
finance.yahoo.com logoSee what the IHS Markit Score report has to say about Quest Diagnostics Inc.
finance.yahoo.com - August 12 at 5:16 PM
americanbankingnews.com logoQuest Diagnostics Incorporated (DGX) Given New $92.00 Price Target at Morgan Stanley
www.americanbankingnews.com - August 10 at 5:02 PM
americanbankingnews.com logo Analysts Anticipate Quest Diagnostics Incorporated (DGX) Will Post Quarterly Sales of $1.94 Billion
www.americanbankingnews.com - August 9 at 7:52 AM
americanbankingnews.com logoQuest Diagnostics Incorporated (NYSE:DGX) Director Jeffrey M. Leiden Sells 296 Shares
www.americanbankingnews.com - August 8 at 8:34 PM
americanbankingnews.com logoQuest Diagnostics Incorporated (NYSE:DGX) Given Consensus Rating of "Buy" by Analysts
www.americanbankingnews.com - August 8 at 2:44 PM
americanbankingnews.com logoQuest Diagnostics Incorporated (NYSE:DGX) Downgraded by Zacks Investment Research
www.americanbankingnews.com - August 3 at 12:30 PM
americanbankingnews.com logoQuest Diagnostics Incorporated (NYSE:DGX) Stock Rating Upgraded by Zacks Investment Research
www.americanbankingnews.com - August 2 at 2:36 PM
finance.yahoo.com logoMountainside Fitness Partners with Sonora Quest Laboratories to Offer Customized Wellness Testing to Health Club Members
finance.yahoo.com - August 1 at 6:34 PM
americanbankingnews.com logoInsider Selling: Quest Diagnostics Incorporated (NYSE:DGX) Director Sells 1,304 Shares of Stock
www.americanbankingnews.com - July 31 at 7:44 PM
americanbankingnews.com logoCraig Hallum Comments on Quest Diagnostics Incorporated's FY2017 Earnings (NYSE:DGX)
www.americanbankingnews.com - July 31 at 8:40 AM
americanbankingnews.com logoZacks Investment Research Downgrades Quest Diagnostics Incorporated (NYSE:DGX) to Hold
www.americanbankingnews.com - July 29 at 12:23 AM
americanbankingnews.com logoKeyCorp Weighs in on Quest Diagnostics Incorporated's FY2018 Earnings (DGX)
www.americanbankingnews.com - July 28 at 6:35 PM
americanbankingnews.com logoJefferies Group Comments on Quest Diagnostics Incorporated's Q3 2017 Earnings (NYSE:DGX)
www.americanbankingnews.com - July 28 at 7:49 AM
finance.yahoo.com logoQuest Diagnostics, Inc. :DGX-US: Earnings Analysis: Q2, 2017 By the Numbers : July 27, 2017
finance.yahoo.com - July 27 at 6:16 PM

Social

Chart

Quest Diagnostics Incorporated (DGX) Chart for Friday, September, 22, 2017

This page was last updated on 9/22/2017 by MarketBeat.com Staff